Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II TrialChunyan Lan, Xin Huang, Yin Wang et al.|Journal of Clinical Oncology|2020Cited by 217